# Kardium

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kardium

- Industry: Medical Devices & Equipment
- Headquarters: Burnaby, Canada
- Website: www.kardium.com
- Latest round: Series D (Jun 1, 2015)
- Investors on record: 1

## About

Based in Burnaby, Canada, and founded in 2007 Kardium Inc. is a medical solutions company that provides devices for the treatment of atrial fibrillation. The company was co-founded by Kevin Chaplin and Doug Goertzen and has approximately 153 employees. In July 2025, Kardium Inc. raised USD 250 million in venture funding co-led by Janus Henderson Investors, Qatar Investment Authority, Mm Capital, Piper Sandler & Co., Eckuity Capital, and Eventide Asset Management, with participation from T Rowe Price, Durable Capital Partners, and other unspecified investors. The company’s team of engineers, medical researchers, and compliance and production staff provides Globe Mapping and Ablation System, a detailed electrophysiological mapping, stimulation, (radio-frequency) RF energy to heat and ablate cardiac tissue within the left atrium and uses ablation of cardiac tissue. The company generates revenue by offering the developed medical devices to pharmaceutical companies. The company will use the July 2025 funding to secure regulatory approvals for its Globe System, expand its manufacturing facilities and production capacity, and create a clinical support and commercial team for the commercial launch of the system.

## Funding rounds

- Series D, Jun 1, 2015 — Conconi Growth Partners

## Investors

- Conconi Growth Partners (https://capitalatlas.ai/funds/conconi-growth-partners) — Series D